256 related articles for article (PubMed ID: 32513741)
1. cGMP via PKG activates 26S proteasomes and enhances degradation of proteins, including ones that cause neurodegenerative diseases.
VerPlank JJS; Tyrkalska SD; Fleming A; Rubinsztein DC; Goldberg AL
Proc Natl Acad Sci U S A; 2020 Jun; 117(25):14220-14230. PubMed ID: 32513741
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms That Activate 26S Proteasomes and Enhance Protein Degradation.
Goldberg AL; Kim HT; Lee D; Collins GA
Biomolecules; 2021 May; 11(6):. PubMed ID: 34067263
[TBL] [Abstract][Full Text] [Related]
3. cAMP-induced phosphorylation of 26S proteasomes on Rpn6/PSMD11 enhances their activity and the degradation of misfolded proteins.
Lokireddy S; Kukushkin NV; Goldberg AL
Proc Natl Acad Sci U S A; 2015 Dec; 112(52):E7176-85. PubMed ID: 26669444
[TBL] [Abstract][Full Text] [Related]
4. 26S Proteasomes are rapidly activated by diverse hormones and physiological states that raise cAMP and cause Rpn6 phosphorylation.
VerPlank JJS; Lokireddy S; Zhao J; Goldberg AL
Proc Natl Acad Sci U S A; 2019 Mar; 116(10):4228-4237. PubMed ID: 30782827
[TBL] [Abstract][Full Text] [Related]
5. Regulating protein breakdown through proteasome phosphorylation.
VerPlank JJS; Goldberg AL
Biochem J; 2017 Sep; 474(19):3355-3371. PubMed ID: 28947610
[TBL] [Abstract][Full Text] [Related]
6. Tau-driven 26S proteasome impairment and cognitive dysfunction can be prevented early in disease by activating cAMP-PKA signaling.
Myeku N; Clelland CL; Emrani S; Kukushkin NV; Yu WH; Goldberg AL; Duff KE
Nat Med; 2016 Jan; 22(1):46-53. PubMed ID: 26692334
[TBL] [Abstract][Full Text] [Related]
7. Activation of phosphodiesterase 5 and inhibition of guanylate cyclase by cGMP-dependent protein kinase in smooth muscle.
Murthy KS
Biochem J; 2001 Nov; 360(Pt 1):199-208. PubMed ID: 11696008
[TBL] [Abstract][Full Text] [Related]
8. Cyclic nucleotide signaling changes associated with normal aging and age-related diseases of the brain.
Kelly MP
Cell Signal; 2018 Jan; 42():281-291. PubMed ID: 29175000
[TBL] [Abstract][Full Text] [Related]
9. The deubiquitinating enzyme Usp14 allosterically inhibits multiple proteasomal activities and ubiquitin-independent proteolysis.
Kim HT; Goldberg AL
J Biol Chem; 2017 Jun; 292(23):9830-9839. PubMed ID: 28416611
[TBL] [Abstract][Full Text] [Related]
10. 26S proteasomes become stably activated upon heat shock when ubiquitination and protein degradation increase.
Lee D; Goldberg AL
Proc Natl Acad Sci U S A; 2022 Jun; 119(25):e2122482119. PubMed ID: 35704754
[TBL] [Abstract][Full Text] [Related]
11. Protein kinase g positively regulates proteasome-mediated degradation of misfolded proteins.
Ranek MJ; Terpstra EJ; Li J; Kass DA; Wang X
Circulation; 2013 Jul; 128(4):365-76. PubMed ID: 23770744
[TBL] [Abstract][Full Text] [Related]
12. PDE1 inhibition facilitates proteasomal degradation of misfolded proteins and protects against cardiac proteinopathy.
Zhang H; Pan B; Wu P; Parajuli N; Rekhter MD; Goldberg AL; Wang X
Sci Adv; 2019 May; 5(5):eaaw5870. PubMed ID: 31131329
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of the inositol 1,4,5-trisphosphate receptor. Cyclic GMP-dependent protein kinase mediates cAMP and cGMP dependent phosphorylation in the intact rat aorta.
Komalavilas P; Lincoln TM
J Biol Chem; 1996 Sep; 271(36):21933-8. PubMed ID: 8702997
[TBL] [Abstract][Full Text] [Related]
14. Ubiquitinated proteins promote the association of proteasomes with the deubiquitinating enzyme Usp14 and the ubiquitin ligase Ube3c.
Kuo CL; Goldberg AL
Proc Natl Acad Sci U S A; 2017 Apr; 114(17):E3404-E3413. PubMed ID: 28396413
[TBL] [Abstract][Full Text] [Related]
15. Evidence for amylase release by cGMP via cAMP-dependent protein kinase in rat parotid acinar cells.
Kuroki H; Imai A; Nashida T; Shimomura H
Arch Oral Biol; 2007 Oct; 52(10):905-10. PubMed ID: 17559798
[TBL] [Abstract][Full Text] [Related]
16. Cyclic AMP and cyclic GMP activate protein kinase G in cavernosal smooth muscle cells: old age is a negative factor.
Lin CS; Liu X; Chow S; Lue TF
BJU Int; 2002 Apr; 89(6):576-82. PubMed ID: 11942968
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of phosphodiesterase-5 by cyclic nucleotide-dependent protein kinase alters its catalytic and allosteric cGMP-binding activities.
Corbin JD; Turko IV; Beasley A; Francis SH
Eur J Biochem; 2000 May; 267(9):2760-7. PubMed ID: 10785399
[TBL] [Abstract][Full Text] [Related]
18. cAMP- and cGMP-elevating agents inhibit GPIbα-mediated aggregation but not GPIbα-stimulated Syk activation in human platelets.
Makhoul S; Trabold K; Gambaryan S; Tenzer S; Pillitteri D; Walter U; Jurk K
Cell Commun Signal; 2019 Sep; 17(1):122. PubMed ID: 31519182
[TBL] [Abstract][Full Text] [Related]
19. Feedback control through cGMP-dependent protein kinase contributes to differential regulation and compartmentation of cGMP in rat cardiac myocytes.
Castro LR; Schittl J; Fischmeister R
Circ Res; 2010 Nov; 107(10):1232-40. PubMed ID: 20847310
[TBL] [Abstract][Full Text] [Related]
20. Modulation of soluble guanylate cyclase activity by phosphorylation.
Murthy KS
Neurochem Int; 2004 Nov; 45(6):845-51. PubMed ID: 15312978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
